Transcatheter local thrombolysis in patients with extensive TIPS thrombosis

Rossle, 1998, The first decade of the transjugular intrahepatic portosystemic shunt (TIPS): state of the art, Liver, 18, 73, 10.1111/j.1600-0676.1998.tb00132.x Rossle, 2004, TIPS: an update, Best Pract Res Clin Gastroenterol, 18, 99, 10.1016/j.bpg.2003.08.004 Murphy, 1998, Long-term follow-up after TIPS: use of Doppler velocity criteria for detecting elevation of the portosystemic gradient, J Vasc Interv Radiol, 9, 275, 10.1016/S1051-0443(98)70269-6 Shiffman, 1996, Can anticoagulation enhance TIPS patency?, Hepatology, 24, 1533, 10.1002/hep.510240637 Siegerstetter, 1999, Platelet aggregation and platelet-derived growth factor inhibition for prevention of insufficiency of the transjugular intrahepatic portosystemic shunt: a randomized study comparing trapidil plus ticlopidine with heparin treatment, Hepatology, 29, 33, 10.1002/hep.510290139 Bureau, 2004, Improved clinical outcome using polytetrafluoroethylene-coated stents for TIPS: results of a randomized study, Gastroenterology, 126, 469, 10.1053/j.gastro.2003.11.016 Janssen, 2000, Factor V Leiden mutation, prothrombin gene mutation, and deficiencies in coagulation inhibitors associated with Budd-Chiari syndrome and portal vein thrombosis: results of a case-control study, Blood, 96, 2364 Denninger, 2000, Cause of portal or hepatic venous thrombosis in adults: the role of multiple concurrent factors, Hepatology, 31, 587, 10.1002/hep.510310307 Papatheodoridis, 1999, Transjugular intrahepatic portosystemic shunt compared with endoscopic treatment for prevention of variceal rebleeding: a meta-analysis, Hepatology, 30, 612, 10.1002/hep.510300316 van Buuren, 2003, Transjugular intrahepatic portosystemic shunt (TIPS): indications and long-term patency, Scand J Gastroenterol Suppl, 100, 10.1080/00855920310002771 Tripathi, 2004, ‘Ten years’ follow-up of 472 patients following transjugular intrahepatic portosystemic stent-shunt insertion at a single centre, Eur J Gastroenterol Hepatol, 16, 9, 10.1097/00042737-200401000-00003 ter Borg, 2004, Transjugular intrahepatic portosystemic shunts: long-term patency and clinical results in a patient cohort observed for 3–9 years, Radiology, 231, 537, 10.1148/radiol.2312021797 Blum, 1995, Noncavernomatous portal vein thrombosis in hepatic cirrhosis: treatment with transjugular intrahepatic portosystemic shunt and local thrombolysis, Radiology, 195, 153, 10.1148/radiology.195.1.7892458 Leebeek, 1998, Budd-Chiari syndrome, portal vein and mesenteric vein thrombosis in a patient homozygous for factor V Leiden mutation treated by TIPS and thrombolysis, Br J Haematol, 102, 929, 10.1046/j.1365-2141.1998.00860.x Aytekin, 2001, Catheter-directed thrombolysis with transjugular access in portal vein thrombosis secondary to pancreatitis, Eur J Radiol, 39, 80, 10.1016/S0720-048X(01)00289-3 Kercher, 2002, Transhepatic thrombolysis in acute portal vein thrombosis after laparoscopic splenectomy, Surg Laparosc Endosc Percutan Tech, 12, 131, 10.1097/00129689-200204000-00013 Henao, 2003, Treatment of portal venous thrombosis with selective superior mesenteric artery infusion of recombinant tissue plasminogen activator, J Vasc Surg, 38, 1411, 10.1016/S0741-5214(03)01052-8 Sharma, 2004, Pharmacological thrombolysis in Budd-Chiari syndrome: a single centre experience and review of the literature, J Hepatol, 40, 172, 10.1016/j.jhep.2003.09.028 Guglielmi, 2005, Transhepatic fibrinolysis of mesenteric and portal vein thrombosis in a patient with ulcerative colitis: a case report, World J Gastroenterol, 11, 2035, 10.3748/wjg.v11.i13.2035 Hollingshead, 2005, Transcatheter thrombolytic therapy for acute mesenteric and portal vein thrombosis, J Vasc Interv Radiol, 16, 651, 10.1097/01.RVI.0000156265.79960.86 Sherigar, 2005, Abdominal pain secondary to pylephlebitis: an uncommon disease of the portal venous system, treated with local thrombolytic therapy, Dig Dis Sci, 50, 983, 10.1007/s10620-005-2675-9 Kuo, 2006, Catheter-directed thrombolysis and thrombectomy for the Budd-Chiari syndrome in paroxysmal nocturnal hemoglobinuria in three patients, J Vasc Interv Radiol, 17, 383, 10.1097/01.RVI.0000196338.87954.CE Nakai, 2006, Transhepatic catheter-directed thrombolysis for portal vein thrombosis after partial splenic embolization in combination with balloon-occluded retrograde transvenous obliteration of splenorenal shunt, World J Gastroenterol, 12, 5071, 10.3748/wjg.v12.i31.5071 Ozkan, 2006, Percutaneous transhepatic thrombolysis in the treatment of acute portal venous thrombosis, Diagn Interv Radiol, 12, 105 Smalberg, 2008, Risks and benefits of transcatheter thrombolytic therapy in patients with splanchnic venous thrombosis, Thromb Haemost, 100, 1084, 10.1160/TH08-01-0015 Berkowitz, 1997, Incidence and predictors of bleeding after contemporary thrombolytic therapy for myocardial infarction. The Global Utilization of Streptokinase and Tissue Plasminogen activator for Occluded coronary arteries (GUSTO) I Investigators, Circulation, 95, 2508, 10.1161/01.CIR.95.11.2508 Schulman, 2008, Hemorrhagic complications of anticoagulant and thrombolytic treatment: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edition), Chest, 133, S257, 10.1378/chest.08-0674